IL17A and rheumatoid arthritis: Human IL-17, for instance, a proinflammatory cytokine identified in 1995 as a product of activated T cells, is involved in the pathogenesis of RA and many other autoimmune and inflammatory diseases (reviewed in [33]) and constitutes an interesting therapeutic target [34].